MultiGEN Diagnostics Launches DNA Sequencing Technology
San Diego-based MultiGEN Diagnostics Inc. has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics.
Read MoreSearch Results for: infectious diseases
Point-of-Care Products: Highlights, Trends and Emerging Technologies
Point-of-care testing aims to improve health care with quick turnaround times.
Read MoreMultiGEN Diagnostics Receives California License for Patient Testing
ultiGEN Diagnostics Inc has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics.
Read MoreGen-Probe Begins Trichomonas Vaginalis Assay Clinical Study on the TIGRIS System
Gen-Probe Inc announces that the company has begun a clinical trial intended to secure U.S. regulatory approval of its APTIMA assay for Trichomonas vaginalis on the fully automated TIGRIS system.
Read MoreBD Adds Surveillance Capability to Infectious Disease Portfolio
BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced the expansion of its portfolio of tools to prevent and control infectious diseases by adding software systems for the surveillance of infections and associated risk factors among patients and healthcare workers, and in the community.
Read More